or Try an Advanced Search...

    Hormone Therapy Stocks List

    Symbol Grade Name % Change
    NVO F Novo Nordisk A/S -0.01
    TXMD F TherapeuticsMD, Inc. -0.06
    KDLY F Kindly MD, Inc. -3.97
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Medical Care Facilities
    Related Stock Lists: Endocrine System Pharmaceutical Products Acid Anti Diabetic Drugs Behavioral Healthcare Biopharmaceutical Chronic Pain Diabetes Diabetes Care Drug Discovery Flash Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Healthcare Products Healthcare Providers Healthcare Service Hormones Hot Flash

    Related ETFs - A few ETFs which own one or more of the above listed Hormone Therapy stocks.

    Symbol Grade Name Weight
    EDEN D iShares MSCI Denmark Capped ETF 22.75
    OZEM D Roundhill GLP-1 & Weight Loss ETF 17.47
    THNR F Amplify Weight Loss Drug & Treatment ETF 13.45
    PPH D Market Vectors Pharmaceutical ETF 8.32
    PJIO D PGIM Jennison International Opportunities ETF 6.5
    View all Hormone Therapy ETFs...
    Compare ETFs
    Compare EDEN to THNR Compare OZEM to PPH Compare PPH to PJIO

        Hormone Therapy Stocks Recent News

        Date Stock Title
        Nov 1 NVO Election Day, Fed decision, earnings: What to Watch Next Week
        Nov 1 NVO Why iShares’ Europe ETF (IEUR) May Be Attractive for U.S. Investors
        Nov 1 NVO Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
        Nov 1 NVO Novo Nordisk's Semaglutide Trial Shows 'Superior Improvement' in Liver Fibrosis, MASH
        Nov 1 NVO Novo Nordisk Says Wegovy Improved Patients’ Liver Disease
        Nov 1 NVO Popular Weight Loss Drug Wegovy Shows Encouraging Results in Liver Fibrosis Trial
        Nov 1 NVO Novo Nordisk posts Phase 3 win for obesity drug in MASH
        Nov 1 NVO Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial
        Nov 1 NVO Novo, with new results, to seek approval for obesity drug in MASH
        Oct 31 NVO Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO
        Oct 31 KDLY Ricky Williams And Wellness Experts Discuss Strategies For Cannabis Patient-Centric Care
        Oct 30 NVO Knockoff weight loss drugs are having a moment. Eli Lilly isn't worried
        Oct 30 NVO Eli Lilly plans to begin advertising weight-loss drug Zepbound
        Oct 30 NVO Lilly's Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock Tanks
        Oct 30 NVO Novo takes big step toward ending Ozempic, Wegovy shortages
        Oct 30 NVO Eli Lilly drops, sending Novo lower after Q3 miss
        Oct 30 NVO Eli Lilly stock sinks after Q3 earnings miss Wall Street expectations
        Oct 30 NVO Eli Lilly Stock Tumbles as Q3 Sales, Profits Fall Well Short of Estimates
        Oct 30 NVO The Zacks Analyst Blog Apple, Novo Nordisk, RTX and FONAR
        Oct 30 NVO Lilly shares fall as obesity drug sales miss forecasts
        Related Industries: Biotechnology Drug Manufacturers - Major Medical Care Facilities
        Related Stock Lists: Endocrine System Pharmaceutical Products Acid Anti Diabetic Drugs Behavioral Healthcare Biopharmaceutical Chronic Pain Diabetes Diabetes Care Drug Discovery Flash Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Healthcare Products Healthcare Providers Healthcare Service Hormones Hot Flash
        Hormone Therapy

        Hormone therapy, also known as hormone replacement therapy (HRT), is a form of medical treatment that replaces hormones that are either not produced in sufficient amounts by the body or are not functioning properly. It is used to treat a variety of conditions, including menopause, infertility, and certain types of cancer. Hormone therapy can involve the use of synthetic hormones, natural hormones, or a combination of both.

        Browse All Tags